Manama: The National Health Regulatory Authority (NHRA) has announced the withdrawal and suspension of registration of the pharmaceutical product “PROTON 40mg E.C TABLET – PROTON 20mg E.C TABLET”, produced by the Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO). The move is based on the warning issued by the Saudi Food and Drug Authority (SFDA) on March 12, 2021. The NHRA indicated said that it has withdrawn the medicine from the Kingdom, and suspended its registration because it does not match the original product. The NHRA recommended the health authorities to withdraw the product as soon as it is available to them, calling on the medicine users to contact their doctors to receive the alternative medication.
Trending
- HH Shaikh Isa bin Ali attends closing ceremony of HH Khalid bin Hamad Schools Basketball Championship
- Education Minister congratulates HH Khalid bin Hamad Schools Basketball Championship winners
- Housing Ministry launches electronic usufruct contract service
- Bahrain chairs extraordinary Arab Foreign Ministers meeting on Iran’s illegal attacks against Arab States
- Saudi non-oil exports achieve annual growth of 15%
- Strong 7.5-magnitude quake off Japan triggers tsunami warnings
- UAE State Security Department reportes dismantling of terrorist organisation plotting to undermine country’s security, stability
- HM King receives HRH Crown Prince of Jordan
